Suppr超能文献

保留喉功能可改善下咽癌患者的治疗效果。

Preservation of laryngeal function improves outcomes of patients with hypopharyngeal carcinoma.

作者信息

Jin Tong, Li Xuezhong, Lei Dapeng, Liu Dayu, Yang Qiuan, Li Guojun, Pan Xinliang

机构信息

Department of Otorhinolaryngology, Qilu Hospital, Shandong University, Key Laboratory of Otolaryngology, Ministry of Health, 107 West Wenhua Road, Jinan, Shandong, 250012, People's Republic of China.

出版信息

Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1785-91. doi: 10.1007/s00405-014-3115-2. Epub 2014 Jun 10.

Abstract

This study compares clinical characteristics and survival between patients with and without laryngeal function (LF) preservation during surgical treatment for hypopharyngeal carcinoma. We retrospectively reviewed 485 cases of hypopharyngeal carcinoma treated at a single institution for analysis. There were 337 cases with and 148 cases without LF preservation after surgery. Preservation of LF was complete in 237 patients and partial in 100 patients. There were significant statistical differences between the preservation group and the group without preservation in T-stage (P < 0.001), overall staging (P < 0.001), and tumor sites (P < 0.001) except the N-stage (P = 0.240). The patients with LF preservation had significantly better overall survival (log-rank, P = 0.005) and a lower risk of death than those without LF preservation (HR 0.62, 95% CI 0.43-0.97), after multivariable adjustment. Treatment with surgery in combination with radiotherapy is still the favorable choice for patients with hypopharyngeal carcinoma. The maximal restoration of pharyngoesophageal continuity and function improves survival for patients whose tumors are excised completely for the preservation of LF and laryngeal and pharyngeal reconstruction.

摘要

本研究比较了下咽癌手术治疗期间保留与未保留喉功能(LF)患者的临床特征和生存率。我们回顾性分析了在单一机构接受治疗的485例下咽癌病例。术后保留LF的有337例,未保留的有148例。237例患者LF完全保留,100例部分保留。除N分期(P = 0.240)外,保留组与未保留组在T分期(P < 0.001)、总体分期(P < 0.001)和肿瘤部位(P < 0.001)方面存在显著统计学差异。多变量调整后,保留LF的患者总生存率显著更高(对数秩检验,P = 0.005),死亡风险低于未保留LF的患者(HR 0.62,95% CI 0.43 - 0.97)。手术联合放疗仍是下咽癌患者的首选治疗方法。对于肿瘤完全切除以保留LF以及进行喉和咽重建的患者,咽食管连续性和功能的最大程度恢复可提高生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be97/4438222/38ac342f04ec/405_2014_3115_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验